Clinical Trial Update: Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of onabotulinumtoxinA for adult upper limb spasticity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Muscle Spasticity, Stroke | Phase 3 | Status: WITHDRAWN